Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Laurus Labs Ltd.
NSE: LAURUSLABS
|
BSE: 540222
|
ISIN: INE947Q01028
|
Industry: Pharmaceuticals
|
Expensive Performer
603.0500
-0.65
(
-0.11
%)
NSE
May 16, 2025
15:31 PM
56.45% Gain from 52W Low
Volume:
1.5M
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Laurus Labs Ltd.
28 Jul 2022
603.05
-0.11%
Laurus Labs (BUY): Synthesis business saves the day
Buy:
Laurus Labs Ltd.
by
BOB Capital Markets Ltd.
Target: 645
Recommendation
BOB Capital Markets Ltd.
Q1 revenue/EBITDA came in 5%/8% above consensus and grew 20%/ 15% YoY to Rs 15.4bn/Rs 4.5bn
Laurus Labs Ltd. has an
average target
of 633.50 from 4 brokers.
More from Laurus Labs Ltd.
Recommended
Five Interesting Stocks Today - May 16, 2025
The Baseline |
16 May 2025
Market closes lower, Center plans to allocate a defence budget of Rs 7 lakh crore by FY27
Trendlyne Marketwatch |
16 May 2025
Earnings Call Transcript - Q1FY21 for Laurus Labs
|
31 Jul 2020